Compare · ACCD vs HCARU
ACCD vs HCARU
Side-by-side comparison of Accolade Inc. (ACCD) and Healthcare Services Acquisition Corporation (HCARU): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while HCARU operates in Finance - the two are in different parts of the market.
- ACCD carries a market cap of $1.18B.
- ACCD has more recent analyst coverage (25 ratings vs 0 for HCARU).
- Company
- Accolade Inc.
- Healthcare Services Acquisition Corporation
- Price
- $7.03+0.00%
- $10.04+0.40%
- Market cap
- $1.18B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Healthcare Services Acquisition Corporation
Healthcare Services Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Bethesda, Maryland.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest HCARU
- SEC Form 15-12G filed by Healthcare Services Acquisition Corporation
- SEC Form 25-NSE filed by Healthcare Services Acquisition Corporation
- Healthcare Services Acquisition Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form SC 13G filed by Healthcare Services Acquisition Corporation
- SEC Form PRE 14A filed by Healthcare Services Acquisition Corporation
- SEC Form 10-Q filed by Healthcare Services Acquisition Corporation
- SEC Form 10-Q filed by Healthcare Services Acquisition Corporation
- SEC Form 10-Q filed by Healthcare Services Acquisition Corporation
- SEC Form 10-K filed by Healthcare Services Acquisition Corporation
- SEC Form 10-Q/A filed by Healthcare Services Acquisition Corporation (Amendment)